Investor Osman Gulseven finds that of hundreds of healthcare companies listed on the New York Stock Exchange, only four fit his investment objective of high profitability, substantial dividends and a maximum P/E ratio of 20. Each is a large-cap drugmaker: AstraZeneca , Bristol-Myers Squibb, Eli Lilly & Co, and Pfizer. Article